Insiders · Profile

Ellis Andrea

Director at BridgeBio Pharma. Filing since 15 Mar 2022. CIK 0001877680

Company
Date
Role
Action
Shares
Amount
Of holding
9 Jul 2026
Director
Sold on a plan
17,167
$1.44M
43.2%
4 Mar 2026
Director
Sold on a plan
64,921
$4.21M
77.7%
5 Aug 2025
Director
Sold on a plan
17,167
$841.18K
48.0%
14 Apr 2025
Director
Sold on a plan
10,000
$350.00K
45.5%
1 Apr 2025
Director
Sold on a plan
30,000
$1.02M
71.4%
15 Mar 2022
Director
Bought
12,000
$100.68K
opened
6 decisions on file.